University of Lynchburg DMSc Doctoral Project Assignment Repository
Specialty
Addiction Medicine
Advisor
Dr. Colletti
Abstract
Abstract
Although opioid overdose deaths have increased exponentially over the last three decades, many barriers exist in treating these patients and delivering the life-sustaining medication, buprenorphine, for opioid use disorder. Numerous studies have examined and analyzed causal factors of the treatment gap in the delivery of buprenorphine. These factors span every area of the healthcare system, and their interplay results in the unnecessary complexity of treating patients with opioid use disorder with buprenorphine. The stigma associated with opioid use disorder, evidence-based treatment recommendations, providers, patients, and society persists despite the overwhelming evidence of the need to increase access to this life-saving medication. Several strategies promise to deliver buprenorphine to a more significant proportion of this population through education, humanization, and improved prescribing of buprenorphine to patients with opioid use disorder and treatment. Interventions to increase access to buprenorphine for this marginalized group of patients should be a national priority.
Recommended Citation
Harrison KS. Prescribing Buprenorphine: The Stigma of Opioid Use Disorder and A Failure to Treat. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2023; 5(1).
Restricted
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.